Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Ly6Chi monocytes regulate T cell responses in viral hepatitis
Jiangao Zhu, Huiyao Chen, Xiaopei Huang, Songfu Jiang, Yiping Yang
Jiangao Zhu, Huiyao Chen, Xiaopei Huang, Songfu Jiang, Yiping Yang
View: Text | PDF
Research Article Immunology Virology

Ly6Chi monocytes regulate T cell responses in viral hepatitis

  • Text
  • PDF
Abstract

Viral hepatitis remains a global health challenge despite recent progress in the development of more effective therapies. Although virus-specific CD8+ and CD4+ T cell responses are essential for viral clearance, it remains largely unknown what regulates T cell–mediated viral clearance. Thus, a better understanding of the regulation of anti-viral T cell immunity would be critical for the design of more effective therapies for viral hepatitis. Using a model of adenovirus-induced hepatitis, here we showed that adenoviral infection induced recruitment of Ly6Chi monocytes to the liver in a CCR2-dependent manner. These recruited Ly6Chi monocytes suppressed CD8+ and CD4+ T cell responses to adenoviral infection, leading to a delay in viral clearance. In vivo depletion of Ly6Chi monocytes markedly enhanced anti-viral T cell responses and promoted viral clearance. Mechanistically, we showed that induction of iNOS and the production of NO by Ly6Chi monocytes are critical for the suppression of T cell responses. In addition, a contact-dependent mechanism mediated by PD-1 and PD-L1 interaction is also required for T cell suppression by Ly6Chi monocytes. These findings suggest a critical role for Ly6Chi monocytes in the regulation of T cell immunity in viral hepatitis and may provide new insights into development of more effective therapies for treating viral hepatitis based on targeting the immunosuppressing monocytes.

Authors

Jiangao Zhu, Huiyao Chen, Xiaopei Huang, Songfu Jiang, Yiping Yang

×

Figure 5

Suppression of T cell proliferation by Ly6Chi monocytes in vitro.

Options: View larger image (or click on image) Download as PowerPoint
Suppression of T cell proliferation by Ly6Chi monocytes in vitro.
(A) CF...
(A) CFSE-labeled splenic T cells (2 × 105) from naive C57BL/6 mice were cultured alone (T cell only) or cocultured with the intrahepatic Ly6Chi monocytes from day 5 adenovirus-infected mice at various ratios of 1:1, 1:2, and 1:4 (Monocytes/T cells), or Ly6G+ granulocytes at a ratio of 1:1 (Granulocytes/T cells), in the presence of anti-CD3 and anti-CD28 Ab stimulation (2 μg/ml of each) for 3 days, and analyzed for proliferation of CD4+ and CD8+ T cells by CFSE dilution. (B) CFSE-labeled HA-specific CD4+ (from 6.5 HA-TCR transgenic mice) and CD8+ (from naive clone 4 HA-TCR transgenic mice) T cells were stimulated alone for 72 hours with the relevant HA class II (10 μg/ml) or HA class I (2 μg/ml) peptides, respectively, or in the presence of the intrahepatic Ly6Chi monocytes from day 5 adenovirus-infected mice at a monocyte to T cell ratio of 1:2 (+Monocytes), or Ly6G+ granulocytes at a granulocyte to T cell ratio of 1:2 (+Granulocytes). Results are representative of 3 independent experiments.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts